相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3 '-kinase (PI3K)/AKT pathway in ovarian cancer cells
Seung Bae Rho et al.
GYNECOLOGIC ONCOLOGY (2011)
mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
Seiji Mabuchi et al.
CLINICAL CANCER RESEARCH (2009)
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
Seiji Mabuchi et al.
CLINICAL CANCER RESEARCH (2007)
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
X. Wan et al.
ONCOGENE (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Akt-mediated cisplatin resistance in ovarian cancer: Modulation of p53 action on caspase-dependent mitocliondrial death pathway
XK Yang et al.
CANCER RESEARCH (2006)
Phosphatidylinostol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma
LM Hu et al.
CLINICAL CANCER RESEARCH (2005)
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth
DA Altomare et al.
ONCOGENE (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
PI3K/Akt and apoptosis: size matters
TF Franke et al.
ONCOGENE (2003)
Depression in palliative care: a systematic review. Part 2. Treatment
KL Ly et al.
PALLIATIVE MEDICINE (2002)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
Fever and sweats in the patient with advanced cancer
DS Zhukovsky
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2002)
Thioridazine interacts with the membrane of mitochondria acquiring antioxidant activity toward apoptosis - potentially implicated mechanisms
T Rodrigues et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α
DA Fruman et al.
NATURE GENETICS (2000)
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer
ZQ Yuan et al.
ONCOGENE (2000)